Real-World Cost-Effectiveness Analysis of Spinal Cord Stimulation vs Conventional Therapy in the Management of Failed Back Surgery Syndrome
Open Access
- 1 September 2021
- journal article
- research article
- Published by Taylor & Francis in Journal of Pain Research
- Vol. ume 14, 3025-3032
Abstract
Purpose: Failed back surgery syndrome (FBSS) causes disability and lowers health-related quality of life (HRQoL) for patients. Many patients become refractory to conventional medical management (CMM) and spinal cord stimulation (SCS) is advised. However, comparative cost-effectiveness research of both clinical approaches still lacks further evidence. This probabilistic cost-effectiveness analysis compares CMM versus SCS plus CMM in FBSS patients for a 5-year period in Spain. Patients and Methods: Patient-level data was obtained from a 2-year real-world study (SEFUDOCE) of adults diagnosed with FBSS who were treated with CMM or SCS. Incremental cost-effectiveness ratios (ICER) were estimated in terms of direct clinical cost and quality-adjusted life years (QALYs). Costs (€ for 2019) were estimated from the Spanish National Health Service (NHS) perspective. We applied a yearly discount rate of 3% to both costs and outcomes and performed a probabilistic sensitivity analysis using bootstrapping. Results: After 2 years, the health-related quality of life measured by the EQ-5D displayed greater improvements for SCS patients (00.39) than for improved CMM patients (0.01). The proportion of SCS patients using medication fell substantially, particularly for opioids (− 49%). In the statistical model projection, compared with the CMM group at year 5, the SCS group showed an incremental cost of € 15,406 for an incremental gain of 0.56 0.56 QALYs, for an ICER of € 27,330, below the € 30,000 willingness-to-pay threshold for Spain. SCS had a 79% of probability of being cost-effective. Conclusion: SCS is a cost-effective treatment for FBSS compared to CMM alone based on real-world evidence.Keywords
This publication has 25 references indexed in Scilit:
- Spinal Cord Stimulation in Pain Management: A ReviewThe Korean Journal of Pain, 2012
- Using the SAFE Principles When Evaluating Electrical Stimulation Therapies for the Pain of Failed Back Surgery SyndromeNeuromodulation: Technology at the Neural Interface, 2011
- The Cost-effectiveness of Spinal Cord Stimulation in the Treatment of Failed Back Surgery SyndromeThe Clinical Journal of Pain, 2010
- Spanish recommendations on economic evaluation of health technologiesThe European Journal of Health Economics, 2010
- Relationship between Health-Related Quality of Life, Pain, and Functional Disability in Neuropathic Pain Patients with Failed Back Surgery SyndromeValue in Health, 2010
- Demographic Characteristics of Patients with Severe Neuropathic Pain Secondary to Failed Back Surgery SyndromePain Practice, 2009
- Spinal cord stimulation versus conventional medical management for neuropathic pain: A multicentre randomised controlled trial in patients with failed back surgery syndromePain, 2007
- Spinal Cord Stimulation vs. Conventional Medical Management: A Prospective, Randomized, Controlled, Multicenter Study of Patients with Failed Back Surgery Syndrome (PROCESS Study)Neuromodulation: Technology at the Neural Interface, 2005
- ¿Qué es una tecnología sanitaria eficiente en España?Gaceta Sanitaria, 2002
- Linear regression analysis of censored medical costsBiostatistics, 2000